{"entity":{"id":"nct07662395","kind":"trial","name":"SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer","aka":[],"tldr":"A phase 2/3 trial testing SCTB41 in non-small-cell lung cancer, now recruiting.","summary":"SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer is a phase 2/3 interventional study registered as NCT07662395, led by Sinocelltech, and recruiting on the registry. Official title: A Multicenter Phase II/III Study Evaluating the Efficacy and Safety of SCTB41 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Driver-Negative Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC). Planned enrolment is 410 participants (estimated). The study started in 2026-05-09 and primary completion is expected in 2030-01-24. No results have been posted on ClinicalTrials.gov.","status":"recruiting","asOf":"2026-09-11","links":[{"label":"ClinicalTrials.gov NCT07662395","url":"https://clinicaltrials.gov/study/NCT07662395"}],"tags":["ctgov-ingest"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":["sctb41"],"companies":["sinocelltech"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07662395","phase":"2/3","setting":"A Multicenter Phase II/III Study Evaluating the Efficacy and Safety of SCTB41 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Driver-Negative Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)","sponsor":"Sinocelltech","participation":[{"nct":"NCT07662395","source":"https://clinicaltrials.gov/study/NCT07662395","fetchedAt":"2026-10-07T16:55:56.330Z","studySha256":"ab186ed87ffc37c2eb63ab6e40850387b15a337bf6ebf41f514f9565b02fe752","overallStatus":"RECRUITING","lastUpdatePosted":"2026-06-23","leadSponsor":"Sinocelltech Ltd.","collaboratorCount":0,"minimumAge":"18 Years","sex":"ALL","healthyVolunteers":false,"hasEligibility":true,"enrolment":410,"enrolmentType":"ESTIMATED","siteCount":1,"recruitingSiteCount":1,"countries":["China"]}],"started":"2026-05-09","startedType":"actual","enrolled":410,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07662395/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"drug":[{"id":"sctb41","kind":"drug","name":"SCTB41","route":"/drugs/sctb41/"}],"company":[{"id":"sinocelltech","kind":"company","name":"Sinocelltech","route":"/companies/sinocelltech/"}]}}